Medical School · Year 3 · General Surgery · includes a quiz and discussion video

Seminar 12: Hepatobiliary Surgery

General Surgery Clerkship - Unit 12

Learning Objectives

By the end of this seminar, students will be able to:

1. Describe hepatic segmental anatomy, blood supply, and biliary drainage patterns essential for surgical planning
2. Evaluate the clinical spectrum of gallstone disease and apply appropriate diagnostic and management strategies
3. Recognize risk factors for bile duct injury during cholecystectomy and implement strategies for prevention
4. Diagnose choledocholithiasis and cholangitis using clinical criteria and imaging, and select appropriate interventions
5. Stage hepatocellular carcinoma using BCLC criteria and select appropriate treatment based on tumor burden and liver function
6. Apply principles of hepatic resection including assessment of future liver remnant and operative techniques

Seminar Outline

I. Hepatic Anatomy and Segmental Division

The liver represents the largest solid organ in the body, weighing approximately 1500 grams and occupying the right upper quadrant with extension across the midline into the epigastrium. The traditional anatomical division into right and left lobes based on the falciform ligament attachment has been superseded by the functional Couinaud segmental system for surgical planning. Cantlie's line, extending from the gallbladder fossa to the inferior vena cava, divides the liver into functional right and left hemilivers along the plane of the middle hepatic vein rather than the external anatomical landmark of the falciform ligament.

The Couinaud classification divides the liver into eight functionally independent segments, each with its own portal pedicle containing a portal vein branch, hepatic artery branch, and bile duct, along with independent hepatic venous drainage. Segments two, three, and four comprise the left hemiliver, with segments two and three forming the left lateral section to the left of the falciform ligament. Segments five, six, seven, and eight comprise the right hemiliver, with the right portal fissure dividing anterior segments five and eight from posterior segments six and seven. Segment one, the caudate lobe, is unique in having dual portal blood supply from both right and left systems and direct venous drainage into the inferior vena cava.

Understanding these segmental relationships is essential for planning hepatic resections that preserve adequate functional liver remnant while achieving complete tumor clearance. A right hepatectomy removes segments five through eight, while a left hepatectomy removes segments two, three, and four. Extended hepatectomy or trisectionectomy involves removal of more than four segments. Left lateral sectionectomy, one of the most commonly performed hepatic resections, removes segments two and three. The ability to perform anatomic resections following portal pedicles and hepatic vein planes optimizes oncologic outcomes while minimizing blood loss and biliary complications.

The portal triad at the hepatic hilum contains the portal vein posteriorly, the hepatic artery to the left, and the bile duct anteriorly and to the right. Variations in hepatic arterial anatomy occur in approximately forty percent of individuals, with a replaced right hepatic artery arising from the superior mesenteric artery in approximately fifteen percent and a replaced left hepatic artery arising from the left gastric artery in approximately ten percent. Recognition of these variants is essential during hepatic and biliary surgery to prevent inadvertent arterial injury. The three major hepatic veins drain into the inferior vena cava just below the diaphragm, with the middle hepatic vein commonly sharing a trunk with the left hepatic vein.

<image>Panel A: Three-dimensional reconstruction of liver showing Couinaud segments one through eight with color coding and relationship to major hepatic veins. Panel B: Inferior view of the liver demonstrating portal triad structures at the hepatic hilum with normal and variant hepatic arterial anatomy. Panel C: Coronal cross-section showing Cantlie's line dividing functional right and left hemilivers along middle hepatic vein plane. Panel D: Diagram of standard hepatic resections including right hepatectomy, left hepatectomy, and left lateral sectionectomy with segment removal illustrated.</image>

II. Hepatic Blood Supply and Biliary Anatomy

The liver possesses a unique dual blood supply receiving approximately seventy-five percent of its blood flow through the portal vein and twenty-five percent through the hepatic artery, with each vessel contributing approximately fifty percent of hepatic oxygen delivery. The portal vein forms behind the pancreatic neck from the confluence of the superior mesenteric and splenic veins, ascending in the hepatoduodenal ligament to divide into right and left branches at the hepatic hilum. This portal venous inflow carries nutrient-rich blood from the gastrointestinal tract and is essential for hepatocyte metabolism, regeneration, and maintenance of liver function following resection or injury.

The hepatic artery typically arises from the celiac trunk as the common hepatic artery, giving off the gastroduodenal artery before continuing as the proper hepatic artery in the hepatoduodenal ligament. The proper hepatic artery divides into right and left hepatic arteries, with the right hepatic artery typically coursing posterior to the common hepatic duct before entering the liver. The cystic artery usually arises from the right hepatic artery within the hepatocystic triangle. Hepatic arterial flow becomes increasingly important in the setting of portal vein thrombosis, biliary obstruction, and following liver transplantation, where hepatic artery thrombosis results in biliary ischemia and graft failure.

The biliary system begins with intrahepatic bile canaliculi that coalesce into progressively larger ducts following the portal pedicles until the right and left hepatic ducts emerge at the hepatic hilum. The right hepatic duct typically has a shorter extrahepatic course than the left, making it more vulnerable to injury during cholecystectomy. The confluence of right and left hepatic ducts forms the common hepatic duct, which joins the cystic duct from the gallbladder to form the common bile duct. The common bile duct courses in the hepatoduodenal ligament anterior to the portal vein and to the right of the hepatic artery, then passes posterior to the duodenum and through the pancreatic head to enter the duodenum at the ampulla of Vater.

The gallbladder serves as a reservoir for bile concentration and storage, with a capacity of approximately thirty to fifty milliliters. Located on the inferior surface of the liver between segments four and five, the gallbladder is divided into fundus, body, infundibulum, and neck, with the neck continuing as the cystic duct. The triangle of Calot, defined by the cystic duct, common hepatic duct, and inferior edge of the liver, contains the cystic artery and represents the critical zone of dissection during cholecystectomy. Numerous anatomical variations in biliary and cystic arterial anatomy predispose to injury during surgery, emphasizing the importance of careful identification of structures before division.

<image>Panel A: Diagram of hepatic blood supply showing portal vein formation and dual blood supply with percentage contributions of flow and oxygen. Panel B: Normal and variant hepatic arterial anatomy including replaced right hepatic artery from SMA and replaced left hepatic artery from left gastric artery. Panel C: Biliary anatomy from intrahepatic ducts through common bile duct to ampulla of Vater with anatomical landmarks. Panel D: Triangle of Calot illustration showing cystic artery origin, cystic duct, and relationship to critical view of safety.</image>

III. Gallstone Disease and Clinical Spectrum

Gallstones affect approximately ten to fifteen percent of the adult population, with the majority remaining asymptomatic throughout life. Cholesterol stones account for approximately eighty percent of gallstones in Western populations and form when bile becomes supersaturated with cholesterol relative to bile salts and phospholipids. Risk factors for cholesterol stone formation include obesity, female sex, multiparity, rapid weight loss, and certain medications including oral contraceptives. Pigment stones comprise the remaining twenty percent, with black pigment stones forming in the setting of chronic hemolysis or cirrhosis and brown pigment stones associated with biliary infection and stasis.

Asymptomatic gallstones discovered incidentally on imaging require no treatment in most patients, as the annual risk of developing symptoms is approximately one to two percent and the risk of serious complications even lower. Prophylactic cholecystectomy may be considered in specific populations including patients undergoing bariatric surgery, those with porcelain gallbladder due to cancer risk, patients with gallbladder polyps greater than one centimeter, and individuals in remote areas without access to surgical care. Serial imaging is not indicated for asymptomatic stones, and patients should be counseled regarding symptoms that would warrant reevaluation.

Biliary colic represents the most common symptomatic manifestation of gallstone disease, occurring when a stone transiently obstructs the cystic duct. The classic presentation involves episodic right upper quadrant or epigastric pain, often radiating to the back or right scapula, typically precipitated by fatty meals and lasting thirty minutes to several hours before spontaneously resolving. The pain results from gallbladder distension and smooth muscle spasm rather than true colic, and is often accompanied by nausea. Physical examination between episodes is typically normal, and laboratory values including liver function tests are usually within normal limits.

Acute cholecystitis develops when cystic duct obstruction persists, leading to gallbladder inflammation, distension, and potential secondary bacterial infection. Clinical presentation includes persistent right upper quadrant pain exceeding six hours, fever, and positive Murphy sign on examination. Laboratory findings typically demonstrate leukocytosis with or without mild liver function test abnormalities. The Tokyo Guidelines provide severity grading from grade I mild disease without organ dysfunction to grade III severe disease with organ failure, guiding decisions regarding timing of intervention and level of care. Complications of untreated cholecystitis include empyema, gangrenous cholecystitis, and perforation with biliary peritonitis.

<image>Panel A: Pathophysiology diagram showing cholesterol crystallization and gallstone formation in relation to bile salt and phospholipid concentrations. Panel B: Clinical presentation spectrum from asymptomatic gallstones through biliary colic to acute cholecystitis with distinguishing features. Panel C: Ultrasound images demonstrating gallstones with acoustic shadowing, gallbladder wall thickening, and pericholecystic fluid in acute cholecystitis. Panel D: Tokyo Guidelines severity stratification for acute cholecystitis with criteria for grades I, II, and III.</image>

IV. Cholecystectomy and Prevention of Bile Duct Injury

Laparoscopic cholecystectomy has become the gold standard treatment for symptomatic gallstone disease, with over 750,000 procedures performed annually in the United States. Indications include symptomatic cholelithiasis with biliary colic, acute cholecystitis, gallstone pancreatitis, and gallbladder polyps greater than one centimeter. Timing of surgery for acute cholecystitis has evolved toward early intervention within seventy-two hours of symptom onset based on evidence demonstrating reduced morbidity, shorter hospital stay, and equivalent complication rates compared to delayed cholecystectomy following initial medical management.

The critical view of safety represents the most important technique for preventing bile duct injury during cholecystectomy. Achievement of the critical view requires complete clearance of the hepatocystic triangle of all fat and fibrous tissue, identification of only two structures entering the gallbladder base representing the cystic duct and cystic artery, and visualization of the inferior third of the gallbladder liver bed. Documentation of the critical view through operative photograph has become standard practice. This technique ensures positive identification of the cystic duct rather than relying on anatomical assumptions, as variations and inflammation can create misleading anatomy that increases injury risk.

Intraoperative cholangiography provides real-time imaging of the biliary tree and may be performed routinely or selectively based on institutional practice and surgeon preference. The procedure involves cannulation of the cystic duct with injection of contrast under fluoroscopic guidance, demonstrating biliary anatomy and identifying common bile duct stones or anatomical variants. While some surgeons advocate routine cholangiography for all cholecystectomies to prevent and identify bile duct injuries, evidence does not conclusively demonstrate reduced injury rates with routine versus selective use. Clear indications include suspected choledocholithiasis, unclear anatomy despite adequate dissection, and concern for bile duct injury.

Management of the difficult gallbladder requires recognition that conversion to open surgery or alternative operative strategies are not failures but rather sound surgical judgment. Severe inflammation, contracted gallbladder, cirrhosis, and previous upper abdominal surgery increase technical difficulty and injury risk. Subtotal cholecystectomy leaving the posterior gallbladder wall attached to the liver bed represents a valid bailout option that eliminates the most dangerous dissection at the hepatocystic triangle. Cholecystostomy tube placement provides temporary decompression in critically ill patients who cannot tolerate definitive surgery. The surgeon must recognize when standard techniques are failing and have a clear escalation plan to prevent major biliary injury.

<image>Panel A: Laparoscopic view demonstrating achievement of critical view of safety with cleared hepatocystic triangle, two structures entering gallbladder base, and visible liver bed. Panel B: Intraoperative cholangiogram showing normal biliary anatomy with contrast filling intrahepatic ducts and common bile duct with flow into duodenum. Panel C: Difficult gallbladder scenarios including severe inflammation, Mirizzi syndrome, and contracted gallbladder with surgical options. Panel D: Subtotal cholecystectomy technique with posterior wall remnant left in situ and closure of cystic stump.</image>

V. Bile Duct Injury Recognition and Management

Bile duct injury during cholecystectomy represents one of the most serious complications in general surgery, occurring in approximately 0.3 to 0.5 percent of laparoscopic cholecystectomies. The Strasberg classification provides a comprehensive system for characterizing injuries from minor cystic duct leaks to complete transection or excision of the common bile duct. Type A injuries include cystic duct leaks and minor hepatic duct injuries that typically respond to endoscopic stenting. Type B and C injuries involve occlusion or transection of aberrant sectoral ducts. Type D represents lateral injury to the main hepatic or common bile duct, while Type E injuries encompass major ductal transection or excision classified by level according to the Bismuth system.

Recognition of bile duct injury requires awareness of both intraoperative and postoperative presentations. Intraoperative recognition occurs in only approximately one-third of cases and may be signaled by unexpected bile in the operative field, identification of an abnormally large duct, or cholangiographic findings inconsistent with expected anatomy. Postoperative presentation typically occurs within the first week and includes abdominal pain, fever, jaundice, and bilious drainage. Delayed presentation with biliary stricture may occur months to years after injury, manifesting as jaundice, cholangitis, or secondary biliary cirrhosis. Laboratory evaluation demonstrates elevated bilirubin and alkaline phosphatase with cholestatic pattern.

Diagnostic imaging for suspected bile duct injury begins with computed tomography to identify bilomas, ductal dilation, and assess the extent of injury. Magnetic resonance cholangiopancreatography provides detailed non-invasive biliary imaging to delineate the level and nature of injury. Endoscopic retrograde cholangiopancreatography serves both diagnostic and therapeutic roles, with ability to demonstrate the injury and provide treatment through sphincterotomy and stent placement for cystic duct leaks and minor injuries. Percutaneous transhepatic cholangiography may be necessary when ERCP cannot access the proximal biliary system due to complete ductal obstruction.

Management of bile duct injury depends on timing of recognition and injury classification. Intraoperatively recognized injuries should prompt immediate expert consultation, as primary repair has worse outcomes than delayed reconstruction in most cases. Drainage of the operative field with appropriate imaging is recommended when expertise is not immediately available. Type E injuries require definitive reconstruction with hepaticojejunostomy performed by experienced hepatobiliary surgeons at high-volume centers. Outcomes of bile duct injury repair correlate strongly with the level of injury, timing of reconstruction, and surgeon experience. Early referral to a tertiary hepatobiliary center optimizes outcomes and minimizes morbidity from this devastating complication.

<image>Panel A: Strasberg classification of bile duct injuries from Type A cystic duct leak through Type E major ductal injuries with anatomical illustrations. Panel B: CT scan showing biloma and ductal dilation following unrecognized bile duct injury with drain placement. Panel C: MRCP demonstrating bile duct stricture at confluence with proximal biliary dilation. Panel D: Roux-en-Y hepaticojejunostomy reconstruction technique for Type E bile duct injury with mucosa-to-mucosa anastomosis.</image>

VI. Choledocholithiasis and Cholangitis

Common bile duct stones occur in approximately ten to fifteen percent of patients with symptomatic gallstone disease and may be present at the time of cholecystectomy or develop subsequently from retained or newly formed stones. Risk stratification based on clinical predictors guides the management approach. High-risk features indicating high probability of choledocholithiasis include common bile duct stone visualized on imaging, clinical cholangitis, or bilirubin greater than four milligrams per deciliter. Intermediate-risk features include abnormal liver function tests, age greater than fifty-five, or dilated common bile duct on imaging. Low-risk patients with none of these features may proceed directly to cholecystectomy without further biliary evaluation.

The management approach follows risk stratification to avoid unnecessary procedures while ensuring detection and treatment of common bile duct stones. Patients with high-risk features should undergo preoperative endoscopic retrograde cholangiopancreatography for stone extraction followed by laparoscopic cholecystectomy. Intermediate-risk patients may undergo preoperative magnetic resonance cholangiopancreatography or endoscopic ultrasound to better define the presence of stones, or may proceed to cholecystectomy with intraoperative cholangiography. Laparoscopic common bile duct exploration provides a single-stage alternative to the two-stage approach of ERCP followed by cholecystectomy for patients with documented choledocholithiasis.

Acute cholangitis represents a life-threatening infection of the biliary system resulting from obstruction combined with bacterial contamination. Charcot's triad of fever, right upper quadrant pain, and jaundice is present in approximately fifty to seventy percent of patients and is highly specific for cholangitis. Reynold's pentad adds hypotension and altered mental status indicating severe sepsis with high mortality. The most common organisms include Escherichia coli, Klebsiella, and Enterococcus species, reflecting enteric flora ascending through an incompetent sphincter of Oddi or introduced through prior instrumentation.

Management of acute cholangitis follows the sepsis resuscitation principles with fluid resuscitation, broad-spectrum antibiotic coverage, and urgent biliary decompression as the cornerstone of source control. The Tokyo Guidelines classify severity and guide timing of drainage, with grade I mild cholangitis potentially responding to antibiotics alone while grade II moderate and grade III severe cholangitis require urgent drainage within twenty-four to forty-eight hours. Endoscopic retrograde cholangiopancreatography with sphincterotomy and stone extraction or stent placement represents the preferred drainage modality. Percutaneous transhepatic biliary drainage provides an alternative when ERCP is unsuccessful or unavailable. Surgical decompression with T-tube placement is rarely necessary in the modern era.

<image>Panel A: Risk stratification algorithm for choledocholithiasis showing high, intermediate, and low probability pathways with recommended evaluation and management. Panel B: ERCP image demonstrating choledocholithiasis with filling defects in dilated common bile duct and balloon extraction of stones. Panel C: Clinical features of acute cholangitis including Charcot's triad and Reynold's pentad with corresponding physiological changes. Panel D: Biliary drainage options including ERCP with stent placement, percutaneous transhepatic drain, and surgical T-tube drainage.</image>

VII. Hepatocellular Carcinoma Epidemiology and Diagnosis

Hepatocellular carcinoma represents the most common primary liver malignancy and the sixth most common cancer worldwide, with incidence continuing to rise in Western countries due to the epidemics of hepatitis C and nonalcoholic fatty liver disease. Approximately eighty to ninety percent of cases arise in the setting of chronic liver disease with cirrhosis, making liver function a critical determinant of treatment options and prognosis. Major risk factors include chronic hepatitis B infection, chronic hepatitis C infection, alcoholic cirrhosis, nonalcoholic steatohepatitis, aflatoxin exposure, and hemochromatosis. Hepatitis B represents the predominant etiology globally while hepatitis C has been more common in Western nations.

Surveillance for hepatocellular carcinoma in at-risk populations enables detection at early stages when curative treatment remains possible. Current guidelines recommend ultrasound with or without alpha-fetoprotein measurement every six months for patients with cirrhosis regardless of etiology and for select non-cirrhotic hepatitis B patients with elevated risk. Elevated alpha-fetoprotein levels greater than 400 nanograms per milliliter in the setting of cirrhosis are highly suggestive of hepatocellular carcinoma, though sensitivity is limited and many tumors do not produce elevated levels. Detection of a suspicious lesion on surveillance ultrasound prompts further evaluation with multiphase contrast-enhanced imaging.

Diagnosis of hepatocellular carcinoma in patients with cirrhosis and nodules greater than one centimeter can often be made noninvasively based on characteristic imaging findings without tissue biopsy. The hallmark enhancement pattern on CT or MRI consists of arterial phase hyperenhancement reflecting hepatic arterial supply followed by washout in the portal venous or delayed phase as the lesion becomes hypodense relative to the enhancing cirrhotic liver parenchyma. The Liver Imaging Reporting and Data System provides standardized categorization of observations from definitely benign through definitely hepatocellular carcinoma. Biopsy is reserved for cases where imaging findings are equivocal or atypical, with the understanding that biopsy carries a small risk of tumor seeding along the needle tract.

Staging of hepatocellular carcinoma requires integration of tumor factors, liver function, and patient performance status, as each independently influences prognosis and treatment selection. The Barcelona Clinic Liver Cancer staging system has been widely adopted, classifying patients from very early stage with single lesion less than two centimeters through terminal stage with severe liver dysfunction or poor performance status. The Milan criteria, defining eligibility for liver transplantation, require either a single tumor less than or equal to five centimeters or up to three tumors each less than or equal to three centimeters without macrovascular invasion or extrahepatic disease. Child-Pugh classification of liver function further stratifies operative risk and candidacy for resection.

<image>Panel A: Global epidemiology map showing hepatocellular carcinoma incidence with regional variations and predominant etiological factors. Panel B: Surveillance algorithm for at-risk populations with ultrasound and AFP intervals and action thresholds. Panel C: Multiphasic CT images demonstrating typical hepatocellular carcinoma enhancement pattern with arterial hyperenhancement and delayed phase washout. Panel D: BCLC staging system flowchart integrating tumor stage, liver function, and performance status with recommended treatments.</image>

VIII. Hepatocellular Carcinoma Treatment

Treatment selection for hepatocellular carcinoma requires careful consideration of tumor burden, underlying liver function, and patient performance status, as therapies appropriate for well-compensated patients may be contraindicated in those with advanced cirrhosis. Surgical resection offers the best outcomes for patients with single tumors without vascular invasion and well-preserved liver function, defined as Child-Pugh class A without significant portal hypertension. Anatomic resection following segmental borders provides optimal local control and margins while preserving functional parenchyma. Five-year survival following resection for early-stage hepatocellular carcinoma in appropriately selected patients reaches fifty to seventy percent, though recurrence rates approach seventy percent at five years due to de novo carcinogenesis in the cirrhotic liver remnant.

Liver transplantation provides the optimal therapy for hepatocellular carcinoma when technically feasible, as it simultaneously removes the tumor and eliminates the cirrhotic liver that serves as a field defect for new tumor development. Patients meeting Milan criteria with single tumor up to five centimeters or up to three tumors each up to three centimeters achieve five-year survival approaching seventy percent, comparable to patients transplanted for non-malignant indications. The Model for End-Stage Liver Disease exception point system provides transplant priority for patients with hepatocellular carcinoma. Locoregional therapies including transarterial chemoembolization and ablation serve as bridge therapy to maintain transplant eligibility while awaiting organ availability.

Locoregional therapies provide treatment options for patients who are not candidates for resection or transplantation. Radiofrequency ablation and microwave ablation deliver thermal energy to destroy tumors, with best outcomes for lesions less than three centimeters not adjacent to major vessels where heat-sink effect may limit efficacy. Transarterial chemoembolization exploits the preferential hepatic arterial supply of hepatocellular carcinoma to deliver chemotherapy and embolic particles directly to tumors while relatively sparing normal liver parenchyma. Radioembolization with yttrium-90 microspheres provides an alternative embolic therapy that delivers localized radiation. These therapies may achieve tumor control and survival benefit in intermediate-stage disease.

Systemic therapy has evolved dramatically with the introduction of targeted agents and immunotherapy. Sorafenib represented the first systemic agent demonstrating survival benefit in advanced hepatocellular carcinoma and remained standard first-line therapy for a decade. The combination of atezolizumab and bevacizumab has now supplanted sorafenib based on improved survival in the IMbrave150 trial. Additional agents including lenvatinib, regorafenib, cabozantinib, and ramucirumab provide options for patients progressing on first-line therapy. Systemic therapy is appropriate for patients with advanced-stage disease characterized by portal vein invasion, extrahepatic spread, or tumor burden beyond locoregional treatment while maintaining preserved liver function and performance status.

<image>Panel A: Treatment algorithm showing surgical resection criteria including single tumor, Child-Pugh A liver function, and absence of portal hypertension. Panel B: Liver transplant candidacy assessment using Milan criteria with tumor size and number thresholds illustrated. Panel C: Transarterial chemoembolization procedure showing catheter positioning, tumor arterial supply, and post-procedure tumor necrosis. Panel D: Systemic therapy timeline showing evolution from sorafenib through combination immunotherapy with survival data.</image>

IX. Hepatic Resection Principles and Techniques

Preoperative assessment for hepatic resection requires evaluation of both tumor factors determining resectability and patient factors determining operative safety. Complete staging with CT or MRI characterizes tumor size, number, location, and relationship to major vascular structures. Resectability requires the ability to achieve negative margins while preserving adequate future liver remnant with intact vascular inflow, outflow, and biliary drainage. Future liver remnant volume is calculated using cross-sectional imaging volumetry and must exceed twenty percent of total liver volume in patients with normal parenchyma, thirty percent following chemotherapy, and forty percent in cirrhotic patients to avoid postoperative liver failure.

When the anticipated future liver remnant is inadequate, strategies exist to induce compensatory hypertrophy before major resection. Portal vein embolization involves percutaneous occlusion of portal branches to the tumor-bearing liver, redirecting portal flow to the future remnant and inducing hypertrophy of approximately ten percent over four to six weeks. This technique has enabled resection in patients previously considered unresectable due to inadequate remnant volume. Associating liver partition and portal vein ligation for staged hepatectomy represents a more aggressive approach achieving rapid hypertrophy over one to two weeks but with higher morbidity. Preoperative optimization including nutritional support, treatment of biliary obstruction, and portal vein embolization reduces the risk of postoperative liver failure.

Intraoperative techniques for hepatic resection center on control of vascular inflow and careful parenchymal transection. The Pringle maneuver involves temporary occlusion of the hepatoduodenal ligament to interrupt hepatic arterial and portal venous inflow, reducing blood loss during parenchymal division. Intermittent clamping with cycles of fifteen minutes clamped and five minutes released minimizes ischemic injury while providing hemostasis. Parenchymal transection may be performed using crush-clamp technique, ultrasonic dissector, bipolar devices, or stapling devices depending on surgeon preference and anatomical circumstances. Low central venous pressure anesthesia reduces hepatic venous pressure and blood loss during transection.

Postoperative management following major hepatic resection focuses on prevention and early recognition of complications. Postoperative liver failure manifests as coagulopathy, encephalopathy, and hyperbilirubinemia, with risk correlating to extent of resection and underlying liver function. Bile leak occurs in approximately five to ten percent of major resections and may be managed conservatively with drainage or require ERCP with stent placement for major leaks from the cut surface. Hemorrhage and perihepatic abscess represent additional complications requiring timely recognition and intervention. Despite these risks, major hepatic resection can be performed with mortality rates of less than three percent at high-volume centers.

<image>Panel A: Preoperative CT volumetry calculating future liver remnant volume with segmental measurements and adequacy thresholds for normal, post-chemotherapy, and cirrhotic liver. Panel B: Portal vein embolization technique showing percutaneous access, coil placement, and follow-up imaging demonstrating compensatory hypertrophy. Panel C: Pringle maneuver illustration with hepatoduodenal ligament clamping and monitoring of intermittent ischemia times. Panel D: Parenchymal transection techniques comparing crush-clamp, ultrasonic dissector, and stapler approaches with hemostatic considerations.</image>

X. Hepatic Trauma and Other Liver Lesions

Hepatic trauma represents the most commonly injured abdominal organ in blunt trauma, resulting from the liver's large size, fixed position, and proximity to the lower ribs. The American Association for the Surgery of Trauma grading system classifies liver injuries from grade I subcapsular hematoma or superficial laceration through grade VI hepatic avulsion. Management has evolved dramatically toward nonoperative approaches for the majority of hepatic injuries, with hemodynamically stable patients managed with observation, serial abdominal examinations, and follow-up imaging regardless of injury grade. Angioembolization provides a valuable adjunct for patients with active arterial extravasation on CT who remain hemodynamically stable.

Operative management of hepatic trauma is indicated for hemodynamic instability unresponsive to resuscitation and for failure of nonoperative management. Damage control principles guide surgical intervention, with the goal of hemorrhage control and contamination containment rather than definitive repair. Perihepatic packing represents the most important technique, controlling hemorrhage through direct pressure while allowing correction of acidosis, hypothermia, and coagulopathy in the intensive care unit. Definitive repair with hepatorrhaphy, resectional debridement, or formal hepatic resection is performed after physiologic stabilization. Complications of hepatic trauma include delayed hemorrhage, biloma, bile leak, hepatic abscess, and hemobilia requiring vigilant monitoring and timely intervention.

Benign liver lesions are commonly encountered on imaging performed for other indications and require accurate characterization to avoid unnecessary intervention. Hepatic hemangioma represents the most common benign liver tumor, demonstrating characteristic peripheral nodular enhancement with centripetal filling on multiphasic imaging. These lesions require no treatment unless symptomatic from mass effect and should never be biopsied due to hemorrhage risk. Focal nodular hyperplasia demonstrates a central scar with arterial phase hyperenhancement and carries no malignant potential, requiring surgery only when diagnostic uncertainty exists. Hepatocellular adenoma occurs predominantly in women using oral contraceptives and carries risks of hemorrhage and malignant transformation, with management ranging from observation to resection based on size, symptoms, and subtype.

Colorectal liver metastases represent the most common malignant liver tumor and have been discussed in the context of metastatic colorectal cancer management. Resection of colorectal liver metastases provides the only chance for long-term survival in appropriately selected patients, with five-year survival of forty to fifty percent following complete resection. Patient selection considers the ability to achieve complete resection with negative margins, adequate future liver remnant, and control of the primary tumor. Neoadjuvant chemotherapy may convert initially unresectable disease to resectable and provides assessment of tumor biology. The principles of hepatic resection including volumetric assessment, portal vein embolization when needed, and meticulous surgical technique apply equally to resection for metastatic disease.

<image>Panel A: AAST liver injury grading scale from grade I through VI with CT examples of subcapsular hematoma, parenchymal laceration, and major vascular injury. Panel B: Management algorithm for hepatic trauma based on hemodynamic status with pathways for observation, angioembolization, and operative intervention. Panel C: Multiphasic imaging characteristics of common benign liver lesions including hemangioma, focal nodular hyperplasia, and hepatocellular adenoma. Panel D: Colorectal liver metastasis management pathway from staging through resectability assessment, neoadjuvant therapy, and surgical resection.</image>

Summary

• The liver is divided into eight Couinaud segments based on portal pedicle distribution and hepatic venous drainage, with Cantlie's line separating functional right and left hemilivers
• The portal vein provides seventy-five percent of hepatic blood flow while the hepatic artery provides twenty-five percent, with each contributing fifty percent of oxygen delivery
• Gallstones affect ten to fifteen percent of adults, with most remaining asymptomatic; biliary colic and acute cholecystitis represent the common symptomatic presentations
• The critical view of safety during cholecystectomy requires clearance of the hepatocystic triangle, identification of only two structures entering the gallbladder, and visualization of the liver bed
• Bile duct injury occurs in 0.3 to 0.5 percent of cholecystectomies and requires early referral to experienced hepatobiliary surgeons for optimal outcomes
• Choledocholithiasis management is guided by risk stratification, with high-probability patients undergoing preoperative ERCP and intermediate-risk patients evaluated with MRCP or intraoperative cholangiography
• Acute cholangitis requires fluid resuscitation, antibiotics, and urgent biliary drainage within twenty-four to forty-eight hours based on severity
• Hepatocellular carcinoma staging using the BCLC system integrates tumor burden, liver function, and performance status to guide treatment selection
• Liver resection requires future liver remnant greater than twenty percent in normal liver, thirty percent after chemotherapy, or forty percent in cirrhosis
• Hepatic trauma is managed nonoperatively in hemodynamically stable patients regardless of injury grade, with operative intervention reserved for instability or failed observation

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown